These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3178174)

  • 21. Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
    Gianni L; Baselga J; Eiermann W; Porta VG; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Cussac AL; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez JJ; Mansutti M; Valagussa P; Bonadonna G
    J Clin Oncol; 2009 May; 27(15):2474-81. PubMed ID: 19332727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer.
    Ejlertsen B; Mouridsen HT; Jensen MB; Bengtsson NO; Bergh J; Cold S; Edlund P; Ewertz M; de Graaf PW; Kamby C; Nielsen DL
    J Clin Oncol; 2006 Nov; 24(31):4956-62. PubMed ID: 17075113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Randomized comparative study of CMF (cyclophosphamide, methotrexate and 5-fluorouracil) and UFT-tamoxifen regimens as adjuvant chemotherapy after surgery for breast cancer: Tochigi Prefectural Study Group for Post-Breast Cancer Adjuvant Chemotherapy].
    Tamura H; Kojima M; Kobayashi H; Ando J; Oka S; Fujisaki M; Wada N; Imoto S; Ikeda T
    Gan To Kagaku Ryoho; 2000 Jul; 27(7):993-1002. PubMed ID: 10925684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
    Isaac N; Panzarella T; Lau A; Mayers C; Kirkbride P; Tannock IF; Vallis KA
    Cancer; 2002 Aug; 95(4):696-703. PubMed ID: 12209711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [5 years' results of a CMF protocol (methotrexate, cyclophosphamide, fluorouracil) of adjuvant chemotherapy in breast cancers].
    Horner-Vallet D; Cappelaere P; Delobelle A; Depadt G; Madelain M; Demaille A
    LARC Med; 1984 Nov; 4(9):532-40. PubMed ID: 6549038
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes].
    Nagykálnai T
    Magy Onkol; 2002; 46(4):307-13. PubMed ID: 12563352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H
    J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma.
    Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P
    Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
    Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
    Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
    Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
    Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of toremifene therapy on serum immunoglobulin levels in breast cancer.
    Paavonen T; Aronen H; Pyrhönen S; Hajba A; Andersson LC
    APMIS; 1991 Sep; 99(9):849-53. PubMed ID: 1832547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological follow-up of acute lymphoblastic leukaemia.
    Krepler P; Pawlowsky J; Kummer M; Brunner R; Eibl M; Pawlowsky G
    Haematologia (Budap); 1976; 10(1):11-22. PubMed ID: 1070465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of radiotherapy on various immunological features in genital and breast carcinoma (author's transl)].
    Reis HE; Feldmann HU; Wetter O; Schmidt CG
    Dtsch Med Wochenschr; 1977 Nov; 102(46):1668-73. PubMed ID: 590094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic monitoring in breast cancer patients receiving postoperative adjuvant chemotherapy.
    Strender LE; Blomgren H; Petrini B; Wasserman J; Forsgren M; Norberg R; Baral E; Wallgren A
    Cancer; 1981 Nov; 48(9):1996-2002. PubMed ID: 6457683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma immunoglobulin levels in patients with breast cancer.
    Wang DY; Goodwin PR; Bulbrook RD; Hayward JL
    Cancer; 1977 May; 39(5):2190-3. PubMed ID: 858130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative radiation therapy and adjuvant chemoimmunotherapy in breast cancer. Aspects of timing and immune competence.
    Klefström P; Nuortio L; Taskinen E
    Acta Radiol Oncol; 1986; 25(3):161-6. PubMed ID: 3020878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood lymphocyte population 4 to 6 years after adjuvant cyclic chemotherapy for operable breast carcinoma.
    Blomgren H; Rotstein S; Petrini B; Wasserman J
    Acta Radiol Oncol; 1985; 24(2):123-7. PubMed ID: 2988273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin levels in breast fluids of women with breast cancer.
    Petrakis NL; Doherty M; Lee R; Mason L; Pawson S; Hunt TK; Schweitzer R
    Clin Immunol Immunopathol; 1977 May; 7(3):386-93. PubMed ID: 872460
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of adjuvant chemotherapy on spontaneous and poke week mitogen triggered immunoglobulin secretion of blood lymphocytes in operable breast cancer.
    Blomgren H; Wasserman J; Rotstein S; Petrini B; von Stedingk LV
    Anticancer Res; 1988; 8(4):839-44. PubMed ID: 3178174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of adjuvant chemotherapy on specific and non-specific immune mechanisms.
    Zielinski CC; Müller C; Kubista E; Staffen A; Eibl MM
    Acta Med Austriaca; 1990; 17(1):11-4. PubMed ID: 2353562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.